Groundbreaking study tackles costly disease - Type 2 diabetes -affecting millions of people worldwide
A groundbreaking study has found that Avandia can prevent the development of Type 2 diabetes in patients with impaired glucose tolerance, a condition affecting millions worldwide. The results have provided proof of concept for a larger prospective study to establish the effectiveness of Avandia in preventing Type 2 diabetes.